Africa UN Knowledge Hub for COVID-19

The Nigerian government says it has begun processes to produce the first candidate vaccine for the prevention of COVID-19, which will be ready in the next 18 months.

Through Africa's post-COVID-19 green recovery pathway, governments have committed to reaching the Paris Agreement's climate change targets

South Africa’s Aspen Pharmacare may be forced to shut down its production of Johnson & Johnson’s single-dose COVID-19 vaccines if African countries do not place orders.

Despite Rwanda’s well-coordinated response, hospitals had been overwhelmed with demand and struggling to keep up.

Aspen Pharmacare, in South Africa, was licensed to produce the Johnson & Johnson vaccine. It was hailed as an answer to Africa’s struggle to get access to vaccines.

Thousands of clinical trials conducted in different parts of the world have shown that COVID-19 vaccines are safe and efficacious.

Ongoing COVID-19 activity in Sub-Saharan Africa indicates the maintenance of basic health precautions.

“Africa had to go through the COVID-19 crisis to realise the importance of investing in strong health systems and pharmaceutical companies that can produce medicines locally”.

The pandemic has been marked by the hoarding of scientific knowledge & life-saving vaccines. Emergency measures in a public health pandemic – called TRIPS flexibilities are not being used”

Africa is intensifying COVID-19 vaccination of high-risk population groups with some promising signs. Nearly 50% of health workers and people over the age of 60 are fully vaccinated against the virus in countries reporting data to World Health Organization (WHO).